Cry toxins produced by Bacillus thuringiensis are insecticidal toxins and have been recently introduced to genetically modified (GM) organisms. The toxins are considered harmless to humans and farm animals; however, it remains unclear whether the toxins affect the mammalian intestinal epithelium, the primary portal and absorption site after ingestion. Therefore, we performed immunohistochemical and ligand blot analyses using brush border membrane vesicles to investigate the interaction of Cry1Ab toxin, a popular Cry toxin developed in GM corn, with bovine intestinal epithelium, with special attention to the presence of Cry1Ab toxin-binding proteins of the epithelial cell. We found that Cry1Ab toxin binds to actin, a cytoskeletal protein. However, the toxin did not bind to aminopeptidase N, cadherin, or alkaline phosphatase, all of which are cell membrane receptors or candidate proteins necessary for the development of toxicity in susceptible insect cells. The present results and previous observations that Cry toxins have little acute toxicity on mammalian cells indicate that Cry1Ab toxin is able to bind to cytoskeletal actin, but that the bovine intestinal epithelial cell lacks membrane receptors, which are necessary for the toxin to exert its toxicity on the cell.
INTRODUCTION
Cry toxins produced by Bacillus thuringiensis are considered to be safe alternatives to chemical insecticides and are being applied in pesticides and genetically modified (GM) organisms. The toxin consists of three domains. Domains II and III bind to the membrane receptor of the midgut epithelium cell in the target insect, whereas Domain I inserts itself into the membrane and forms a pore (Aronson and Shai, 2001; Li et al., 2001 ). This pore changes the ion permeability characteristics of the midgut cell membranes, resulting in an influx of ions and an accompanying influx of water. As a result, the cell lyses, the midgut disintegrates, and the insect dies (Schenepf et al., 1998) . Therefore, the binding of Cry toxins to the surface of the cell is essential for insecticidal activity.
It is presently believed that there are no Cry receptors on mammalian cells because the effect of Cry toxins on mammals has not been confirmed in toxicity tests using rodents (McClintock et al., 1995; Betz et al., 2000) , or performance studies using cattle, pigs, and chickens (Kuiper et al., 2001 ). However, Vázquez-Padrón et al. (2000) reported that one type of Cry1 protoxin (Cry1Ac) bound to the mucosal surface of the mouse small intestine and induced in situ temporal changes in the electrophysiological properties of the mouse jejunum without affecting the macroscopic physiological signals. Although Cry toxins are considered to be easily digested into non-toxic small fragments in the mammalian gastrointestinal tract, we recently detected trace amounts of intact Cry1Ab toxin in the gastrointestinal contents of calves that were fed GM corn containing the toxin (Chowdhury et al., 2003) . In addition, Cry1Ab toxin is easily digested by gastric fluid but is resistant to intestinal fluid (Okunuki et al., 2002) . Cattle under modern intensive rearing management are usually fed concentrated feed containing corn, so it is likely that their intestinal epithelium is frequently exposed to corn-derived Cry toxins. Epithelial cells will be damaged by corn-derived Cry toxins if Cry receptors exist on the bovine intestinal epithelial cells. However, there have been no detailed examinations to clarify whether the toxins interact with and affect the intestinal epithelium, a primary portal site after ingestion, in farm animals.
We investigated the presence of the Cry1Ab toxin-binding protein in bovine intestinal epithelial cells in this study, which is essential for understanding the mode of action of the toxicity. We found that the brush-border membrane vesicle (BBMV) fraction of the bovine intestines contained a Cry1Ab toxin-binding protein. However, our observations strongly indicated that the protein is actin, a cytoskeletal protein of the fraction. The toxin failed to bind to aminopeptidase N, cadherin, or alkaline phosphatase, all of which are considered membrane receptors or receptor candidates for Cry toxins in insects. Actin is an intracellular protein. Therefore, we concluded that mammalian intestinal epithelial cells do not possess membrane receptors for the toxin.
MATERIALS AND METHODS
Cry1Ab preparation. Cry1Ab toxin was obtained as previously described . Briefly, crystalliferous Cry1Ab toxin was purified from an Escherichia coli recombinant strain harboring a cry1Ab gene of B. thuringiensis serovar kurstaki HD-1 and activated to Cry1Ab toxin by trypsinization. The activated Cry1Ab toxin was dialyzed against phosphate-buffered saline (PBS, pH 7.4) and then further dialyzed (4°C, overnight) against 0.05 M Tris-HCl (pH 9.0), which preferentially precipitated Cry1Ab toxin. The precipitate was resuspended in PBS (pH 7.4) and stored at Ϫ80°C before use. The toxicity of the Cry1Ab toxin was confirmed by a bioassay on susceptible silkworm larvae. The protein concentration was determined by DC Protein Assay (BioRad, California, USA), using bovine serum albumin as the standard.
Preparation of Brush-Border Membrane Vesicles (BBMVs). Cattle intestinal BBMV was prepared according to the methodology reported by Hauser et al. with some modification (Hauser et al., 1980) . The small intestine was removed from four healthy cattle (50 and 84 mo old Holsteins and 43 and 85 mo old Japanese Blacks) in accordance with the guidelines for animal use of the National Institute of Animal Health, rinsed with PBS, and cut with scissors into small pieces. The intestinal fragments (20 g wet wt.) were immersed in 50 ml of ice-cold BBMV isolation buffer (300 mM D-mannitol, 5 mM EGTA, 12 mM Tris-HCl, pH 7.1) and homogenized at 4°C using a Potter homogenizer. The homogenate was filtrated and diluted six-fold with ice-cold water, and MgCl 2 was added to 10 mM. The mixture was incubated on ice for 15 min and part of the precipitate was discarded by centrifugation at 3,000ϫg. The BBMVs suspended in the supernatant were collected by centrifugation at 30,000ϫg for 30 min at 4°C. The pellet was resuspended with a 50 ml BBMV isolation buffer, and the above steps were repeated. The final pellet was stored at Ϫ80°C. We tested the quality of the BBMV by measuring the activity of aminopeptidase (Knight et al., 1994) .
Ligand blot and Western blot analyses. Thirty micrograms of BBMV proteins prepared from each of the four cattle were separated by 5% to 20% gradient sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Massachusetts, USA). The membrane was blocked with Block Ace (Dainippon Pharmaceutical, Osaka, Japan) for 1 h at room temperature.
The blocked membrane was incubated with 200 ng/ml of Cry1Ab toxin for 1 h at room temperature for the ligand blots. The membrane was washed three times with PBS containing 0.5% Tween ® 20 for 5 min and incubated with a rabbit anti-Cry1A polyclonal antibody for 1 h at room temperature, and then incubated with horseradish peroxidase-conjugated goat anti-rabbit IgG polyclonal antibody (OEM Concepts, New Jersey, USA) for 0.5 h at room temperature. Anti-Cry1A toxin antiserum was prepared by injecting purified B. sotto Cry1Aa crystal into a rabbit. Booster injections were given three times at 4 wk intervals. The serum was collected 3 d after the final booster and purified to IgG fraction with an Econo-Pac ® Serum IgG Purification Kit (Bio-Rad, California, USA). We confirmed the IgG reactivity to Cry1Ab toxin by immunoblot analysis (data not shown). The immune complexes were revealed using the ECL Plus Western Blotting Detection system (Amersham Biosciences, UK).
The primary antibodies used for immunoblots in the western blot analyses were anti-aminopeptidase N polyclonal antibody (Code: sc-15360, Santa Cruz Biotechnology, California, USA), anti-cadherin polyclonal antibody (Code: M143, Takara, Osaka, Japan), anti-alkaline phosphatase polyclonal antibody (Code: 100-4135, Rockland, Pennsylvania, USA), and anti-actin polyclonal antibody (Code: BT-560, Biomedical Technologies, Massachusetts, USA).
Internal amino acid sequence analysis. The internal amino sequence of the 45 kDa protein of the BBMV fraction was determined as follows. The protein in SDS-PAGE gel was digested by the ingel digestion method described by Rosenfeld et al. (1992) . The peptide fragments obtained were separated by reversed-phase high-performance liquid chromatography on a TSK gel ODS-120T column (0.46ϫ15 cm, Tosoh, Tokyo, Japan) under a linear gradient of 12 to 52% acetonitrile for 80 min in 0.05% trifluoroacetic acid at a flow rate of 1.0 ml/min. Elution was monitored by absorbance at 210 nm. The amino acid sequence of a distinct peptide was determined by automatic sequential Edman degradation using a model 477A gas-phase sequencer (Applied Biosystems, California, USA).
In situ binding assay. The intestines of two healthy Holstein cattle (28 and 29 mo old) were rapidly removed from the animals, in accordance with the guidelines for animal use, of the author's institute, and immediately washed with ice-cold PBS. The intestines were embedded in Tissue-Tek ® O.C.T. Compound (Sakura Finetechnical, Tokyo, Japan), and 6 mm frozen sections were cut. The preparations were stored at Ϫ20°C until use. The tissue sections for the in situ binding assays were thawed and washed in PBS at room temperature for 5 min three times. The sections were subsequently immersed into 0.3% hydrogen peroxide in methanol for 10 min and washed in PBS for 5 min three times. The sections were blocked with Block Ace (Dainippon Pharmaceutical) for 1 h and then incubated with Cry1Ab toxin (0.1 mg/ml in PBS) for 2 h at room temperature. Unbound toxin was removed by washing with PBS containing 2% Triton ® X-100 for 1 min, and the slides were incubated with anti-Cry1A polyclonal antibody at 0.1 mg/ml in PBS containing 0.1% Triton ® X-100 for 1 h at room temperature. The antibodies bound to the sections were labeled with peroxidase using Histofine Simple Stain PO (MULTI) solution (Nichirei, Tokyo, Japan) at room temperature for 30 min, and peroxidase activity was visualized by 3,3Ј-diaminobenzidine. The sections were then counterstained with hematoxylin. Incubation with Cry1Ab toxin was omitted in the control sections. For the visualization of b-actin, sections were incubated for 1 h at room temperature with anti-b-actin monoclonal antibody (Code: A-2228, Sigma, St. Louis, Missouri, USA). The immunocomplex was detected as described above.
Confirming the ligand blot assay. One microgram of bovine serum albumin (Sigma) and 1 mg of human platelet actin (Cytoskeleton, Colorado, USA) were applied to SDS-PAGE and transferred to a PVDF membrane. The membrane was incubated with Cry1Ab toxin, and the bound toxin was detected in the manner described above for the ligand blot.
RESULTS
We analyzed the binding of Cry1Ab toxin to the BBMV proteins immobilized onto a PVDF membrane to clarify the interaction between Cry1Ab toxin and the BBMV proteins at the molecular level. We found that all of the BBMV preparations contained the Cry1Ab toxin-binding protein with a molecular weight of 45 kDa (Fig. 1) . A 30 kDa protein exhibited a weak binding signal in some BBMV preparations. This smaller band was probaCry1Ab Binds to Actin in the Bovine Gut Cell 297 Fig. 1 . Ligand blot assay on BBMV isolated from cattle intestine. BBMV proteins (30 mg) prepared from four cattle were loaded into an SDS-PAGE and blotted to a PVDF membrane. The membrane was incubated with 200 ng/ml of Cry1Ab toxin, and the bound toxin was detected as described in Materials and Methods.
bly a degraded portion of the 45 kDa protein digested by endogenous proteases in the BBMV suspension. The control assay performed without Cry1Ab toxin did not exhibit a binding signal. Previous reports have indicated that there are also Cry toxin-binding proteins with a molecular weight of about 45 kDa in insect BBMV (Aranda et al., 1996; McNall and Adang, 2003) ; we verified the presence of an analogous protein in bovine BBMV samples in further binding analyses as follows.
We investigated the reactivity of the 45 kDa Cry1Ab toxin-binding protein to various antibodies against aminopeptidase N, cadherin, alkaline phosphatase, and actin, all of which are known to be Cry toxin-binding proteins in insects (Knight et al., 1994; Vadlamudi et al., 1995; Yaoi et al., 1997; McNall and Adang, 2003; Bravo et al., 2004) . The Cry1Ab toxin-binding protein only reacted to the anti-actin antibody (Fig. 2) . These results strongly indicate that the 45 kDa protein is actin. The other antibodies detected each corresponding antigen, but these antigens failed to bind to the Cry1Ab toxin.
We determined the internal amino acid sequence of the 45 kDa Cry1Ab toxin-binding protein. The internal amino acid sequence of the suspected protein was identical to that of bovine actin, as indicated in Fig. 3 (Vandekerckhove and Weber, 1978) .
We used immunohistochemistry to examine whether the bovine intestinal epithelial cells contained Cry1Ab toxin-binding proteins. Cry1Ab toxin attached to the intestinal epithelium, particularly to its apical surface (Fig. 4A) . This result agrees with a previous report that Cry1Ac protoxin binds to surface proteins in the mouse small intestine (Vázquez-Padrón et al., 2000) . In addition, we found that the site of Cry1Ab toxin attachments corresponds to the b-actin site (Fig. 4B ). An intestinal tissue section without Cry1Ab toxin did not exhibit a binding signal (Fig. 4C) .
We examined the reactivity of Cry1Ab toxin to human platelet actin (b-actin) immobilized onto a PVDF membrane compared with its reactivity to bovine serum albumin to confirm the connectivity between Cry1Ab toxin and b-actin. The Cry1Ab toxin bound to b-actin more strongly than to bovine serum albumin (Fig. 5) .
DISCUSSION
We used ligand blot assays in this study to demonstrate that there is a Cry1Ab toxin-binding protein in the bovine intestinal epithelial cell. The molecular weight of the protein was identical to that of actin. The suspected protein and bovine bactin contained the same amino acid sequence (12 amino acid residues). Furthermore, in situ analyses of bovine intestinal cells revealed that Cry1Ab toxin bound to the b-actin. This finding strongly suggests that the 45 kDa protein is b-actin. Our finding agrees with a previous report that actin is a novel protein with connectivity to Cry1Ac toxin in a susceptible insect (McNall and Adang, 2003) .
Actin is organized into a cytoskeletal structure that forms a very dynamic intracellular network. It reorganizes continuously as the cell changes its shape, divides, and responds to the environment, and also provides the machinery for intracellular movements such as the transport of organelles (Alberts et al., 1994) . Therefore, if Cry1Ab toxin binds to intracellular actin, that binding may contribute to weakening of the integrity of the cell. However, it seems doubtful that such an interaction can occur in living cells in which the membrane integrity is tightly regulated, since actin is localized intracellularly inside or beneath the microvilli but not on the cell surface (Mooseker and Tilney, 1975) . In addition, we could not find any membrane proteins with an affinity to Cry1Ab toxin by the ligand blot assays in this study. Aminopeptidase N, cadherin, and alkaline phosphatase are considered to be membrane receptors or candidates for triggering the toxicity of Cry toxins in susceptible insects (Knight et al., 1994; Vadlamudi et al., 1995; Yaoi et al., 1997; McNall and Adang, 2003; Bravo et al., 2004) . None of these proteins were detected as Cry1Ab toxin-binding proteins in our bovine BBMV samples. Furthermore, we confirmed that Cry1Ab toxin could not damage the membrane permeability of bovine intestinal epithelial cells (Shimada et al., 2006) . Therefore, we be- lieve that mammalian intestinal epithelial cells may lack Cry1Ab toxin-specific membrane receptors.
We previously found that the Cry1Ab toxin has little acute toxicity for bovine hepatocytes. No morphological or functional changes were confirmed in these cells when they were treated with Cry1Ab toxin . Furthermore, no morphological changes were observed in Cry toxin-treated mouse fibroblasts, primary pig lymphocytes, or mouse epithelial carcinoma cell lines (Thomas and Ellar, 1983) . Our present results, along with the previous observations, indicate that the toxin possesses a binding capacity with cytoskeletal actin, but it may not impair the membrane integrity of the cell, probably due to the lack of the toxin-specific membrane receptors. Additional research is necessary to confirm that the toxin does not affect the membrane integrity or permeability of a mammalian intestinal epithelial cell.
